A recent research at the Oxford University has said that regular use of aspirin for five years can cut overall cancer deaths at least by 20%. The study adds new evidence to the debate about whether otherwise healthy people in their 40s and 50s should consider taking a low dose of aspirin each day, the university release said.
Aspirin is already known to be beneficial for those at high risk of heart disease.
But among healthy people, the benefit in lower chances of heart problems only marginally outweighs the small risk of stomach bleeds.
The large size of the effect now seen in preventing cancer deaths may begin to tip the balance in favour of taking aspirin, the scientists suggest.
There is considerable evidence suggesting aspirin can reduce the risk of getting or dying from many different types of cancer. Early studies suggested the benefits come from taking high doses of aspirin.
The latest work suggests even small doses - 75mg - can reduce the risk of cancer when taken for at least five years.